Candidates will lead research projects that utilize new technologies to identification of microRNA targets responsible for normal lymphocyte development and lymphomagenesis, and their interaction with cell cycle regulators using both pre-clinical models and human tissue samples. Additional research opportunities include the genetic modification of hematopoietic stem cells for the treatment of benign and malignant hematopoietic disease.
Candidates with strong backgrounds in biochemistry, cellular biology, cancer pathogenesis, hematopoietic cell biology, or genomics are strongly encouraged to apply.
Candidates should have a demonstrated ability to take lead position on peer-reviewed publications, secure independent funding, and conduct creative and productive laboratory research projects. The candidate will work with an interdisciplinary team of scientists and collaborators at the University of New Mexico Comprehensive Cancer Center, the University of Washington, and Los Alamos National Laboratories.
Please send Curriculum Vitae, a brief summary of your research interests, and the names, phone numbers and email addresses of three references to email@example.com.
Please visit the Fero Lab home page for more information about us at: http://cancer.unm.edu/research/cancer/fero-lab/